Skip to main content
L

LoBio

This startup offers a device that allows patients to self-collect and mail in plasma samples, eliminating the need for in-person lab visits. The device simplifies the plasma collection process, ensuring sample quality comparable to lab-collected samples, and enabling remote blood draws for patients.

North Bethesda, United States7300+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional blood testing requires patients to visit a lab for blood draws, which can be inconvenient or inaccessible due to mobility issues, location, or time constraints. The need for specialized equipment like centrifuges limits at-home blood sample collection and increases the cost and complexity of remote testing. Current at-home blood collection methods often suffer from high error rates due to improper handling or degradation during shipping.

Solution

LoBio offers a device that enables patients to self-collect plasma samples at home and mail them to a lab, eliminating the need for in-person visits and specialized equipment. The LoBio P1 device utilizes a patented bead technology to efficiently separate clinical-grade plasma from blood without the need for a centrifuge. This allows for accurate and reliable remote blood draws, with sample quality comparable to lab-collected samples. The device simplifies the plasma collection process, reducing error rates associated with traditional at-home blood collection methods and ensuring sample stability during shipping.

Target Audience

LoBio's primary customers are diagnostic laboratories, at-home testing companies, and healthcare providers seeking to offer convenient and accurate remote blood testing services to patients.

Features

  • Patented bead technology for fast and efficient plasma separation without a centrifuge
  • Convenient, power-free device for easy at-home use
  • Enables collection of clinical-grade plasma suitable for a wide range of blood-based biomarker tests
  • Demonstrated excellent correlation with key blood-based biomarkers like lipid, liver, and kidney enzymes
  • Reduces error rates compared to existing at-home blood collection methods
  • Simplifies logistics and reduces costs associated with traditional blood testing
This profile is AI-generated and may contain inaccuracies.